Affymetrix, Asuragen Agree to Supply RNA Control Kits for Molecular Diagnostics
Asuragen Inc has announced an agreement to develop and manufacture RNA Control Kits for Affymetrix.
Read MoreSearch Results for: infectious diseases
QIAGEN, Celera Establish Distribution Agreement for Respiratory Pathogen Panel
QIAGEN NV and Celera Corp announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN’s ResPlex II assay for detection of respiratory pathogens.
Read MoreHIV/AIDS Clinical Diagnostics’ Impressive R&D Significantly Cuts Down Prevalence Rates
Rising consumer awareness that early diagnosis and treatment can delay the progression of human immunodeficiency virus (HIV) to anti-immuno deficiency syndrome (AIDS) has had a telling impact on the sales of HIV tests.
Read More
Focus on HIV and STDs
While molecular assays continue to be the gold standard in accuracy, point-of-care testing also moves to the fore.
Read More
Integrating Integration
Clinical laboratories are increasingly adopting integrated instruments, which offer a number of benefits with the right fit.
Read More